[Study of the expression of neural stem cell markers in neuroblastoma tumor samples and correlation with prognostic factors].

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica

PubMedID: 24482902

Martínez-Criado Y, Cabello R, Fernández-Pineda I, Márquez C, Ramírez G, Rivas E, Robles MJ, Pardal R, Vega FM. [Study of the expression of neural stem cell markers in neuroblastoma tumor samples and correlation with prognostic factors]. Cir Pediatr. 2013;26(3):112-8.
INTRODUCTION
The existence of cancer stem cells (CSC) in neuroblastoma (NB) has been associated with the development of metastasis, resistance to chemotherapy and recurrence. Our objective is to analyze the expression of proliferation and differentiation markers of neural progenitor cells in NB samples, and to correlate this expression with clinical variables such as histology, genetics and response to conventional therapy.

MATERIAL AND METHODS
We performed a retrospective-experimental study with neuroblastoma samples obtained from biopsies or tumor resections between 2010-2012 in our Hospital. Fluorescence immunohistochemistry was used to analyze the expression of the different markers: CD44, CD74, CD133, tyrosine hydroxylase, endothelin receptors type A (ETA) and B (ETB), p75, nestina y and Phox2b, all of them related to neural stem cell biology. The level of expression of the markers was then correlated with clinical variables.

RESULTS
Nestin expression was positive in 72.2% of samples and ETA in 66.7%. PHOX2B and CD74 expression were lower, being positive in less than 30%. The markers CD44, ETB and PHOX2B were expressed in more aggressive tumors. ETA expression correlated significantly with unfavorable histology tumors (p= 0.01), N-myc amplification (p= 0.05) and recurrence/progression (p= 0.05).

CONCLUSION
The expression of CD44, ETB and ETA was associated with more aggressive tumors and poor prognostic factors. These markers are in the membrane of neural stem cells and may be useful to identify and isolate by flow cytometry CSCs of NB for the study of new therapeutic targets.